dichlororibofuranosylbenzimidazole has been researched along with Shock in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Price, BD | 1 |
| Calderwood, SK | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Shock
| Article | Year |
|---|---|
Heat-induced transcription from RNA polymerases II and III and HSF binding activity are co-ordinately regulated by the products of the heat shock genes.
Topics: Animals; Cycloheximide; Dichlororibofuranosylbenzimidazole; DNA-Binding Proteins; Drug Stability; Ge | 1992 |